US 7928194
Recombinant antigen for diagnosis and prevention of murine typhus
granted A61KA61K39/0233A61P
Quick answer
US patent 7928194 (Recombinant antigen for diagnosis and prevention of murine typhus) held by United States of America as represented by the Secretary of the Air Force expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States of America as represented by the Secretary of the Air Force
- Grant date
- Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K39/0233, A61P, A61P31/04, A61P37/04